Back in May, we provided an update on the status of AB2, the bill which would create Community Revitalization Investment Authorities, (see here). Things were relatively quiet over the summer but this ...
Inflammatory diseases specialist AB2 Bio Ltd. has signed a potential $686 million U.S. commercialization deal for its interleukin-18 neutralizing drug tadekinig. The agreement with Japanese pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results